Federal Agency for Medecines and Health Products Federal Agency for Medicines and Health Products (FAMHP) FAMHP/DLT/ 28.01.2010 Lambot Damien Materiovigilance.

Slides:

Advertisements

Similar presentations

And the provisions of….. the Medical Devices Regulations Medical Devices Agency.

Advertisements

Medical Devices The current legislative and administrative structure.

Comparison GHTF/SG5/N5:2012 vs. MEDDEV 2.7/3:2010

Australian Guidance Document Number xx Cathy Thomas Professional Representation OT Australia WA.

Market surveillance. Internal market Enforcement of Community legislation is an obligation on Member States: Article 10 of the EC Treaty requires Member.

Susan Best, NRL, Australia WHO post-market surveillance for In Vitro Diagnostic Devices (IVD)

Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent

JOB FUNCTION EVALUATION Lowering Your Accident Costs.

S4: Market Surveillance Physikalisch-Technische Bundesanstalt Session 4: Market surveillance Peter Ulbig, Harry Stolz Belgrade, 31 October.

OHSAS 18001: Occupational health and safety management systems - Specification Karen Lawrence.

RC14001 ® Update GPCA Responsible Care Committee September 23, 2013.

External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.

CE marking Catriona Blake Team Manager, Imaging, acute and community care.

Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,

FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.

© 2009 Michigan State University licensed under CC-BY-SA, original at Corrective Action.

Requirements of EU pharmacovigilance legislation for distributors Julia Sipos Quality Management Director Pharmacovigilance coordinator Version 03.

Regulatory Update Ellen Leinfuss SVP, Life Sciences.

U D T Workshop on the Pressure Equipment Directive, Warsaw June 2004 INTERFACES BETWEEN NATIONAL LEGISLATION AND DIRECTIVE 97/23/EC SYSTEM OF ENSURING.

Janine Webster (Medical Device Training Officer)

A royal decree was issued on Feb.13, 2007 assigned the responsibility for regulating medical devices, in vitro diagnostic devices, prescription eye glasses,

Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.

FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.

What is Food Recall A food recall is a voluntary action by a manufacturer or distributor to protect the public from products that may cause health problems.

Top 10 Medical Device Citations

1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.

ISO 9001:2000 QUALITY MANAGEMENT SYSTEM REQUIREMENTS

Incident Reports and field Safety Corrective Action ( FSCA) Eng. Essam M. Al-Mohandis Executive Director of Surveillance and Biometrics.

Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.

Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.

© Siemens AG 2014 Alle Rechte vorbehalten.siemens.com/lowvoltage New Legislative Framework (NLF) Sektor Infrastructure & Cities | Division Low and Medium.

4.3 Document control 4.4 Review of requests, tenders and contracts

S tefano S oro European Commission Health and Consumer Protection DG OBLIGATION OF PRODUCERS AND DISTRIBUTORS TO NOTIFY DANGEROUS PRODUCTS.

Chapter 18 Regulations Tracking. Regulations US: FDA, almost all devices, almost all drugs European Community: devices so far, CE mark is the goal. –Active.

Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.

Directorate General for Enterprise and Industry European Commission The New Legislative Framework - Market Surveillance UNECE “MARS” Group meeting Bratislava,

An Introduction to the Privacy Act Privacy Act 1993 Promotes and protects individual privacy Is concerned with the privacy of information about people.

FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,

Product Recall Laws in China Xiangwen Liu Partner King & Wood PRC Lawyers.

WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.

Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.

Laboratory equipment Dr. W. Huisman Cairo, November 21th 2012.

CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.

THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.

WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.

M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 1 – Free movement of goods Bilateral.

©drs.nu, April Introduction to EU Regulation for Wearables.

Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.

Date: in 12 pts MARKET SURVEILLANCE IN THE EU ROLE IN THE NLF - EU ACTIONS and DEVELOPMENTS Rita L'Abbate European Commission DG ENTERPRISE AND INDUSTRY.

Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.

Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.

Budapest 26th april 2005 Seminar on Consumer Protection Protection of consumer health and safety : implementing experience and best practices of the EC.

REGULATION (EC) Nº 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products 1 Shall apply from 11.

PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:

Health and Consumers Health and Consumers Introduction to the new Medical Device Regulations and their impact on medical software DG for Internal Market,

Clusters working group COM/CAMD New Regulations

Safety Alerts between railway actors

The Working Group on Medical Measurements The 23rd Forum Meeting

UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.

“Responsible for Information and Publicity”

Responsible for Information and Publicity Josiane Van der Elst

New European Rules governing medical devices vigilance and combination products Lincoln Tsang May 2008.

Medical Devices.

Drug-device combinations regulated as medicines - Revised regulatory

Evidence standards for device approval: Regulatory perspectives

MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA

2.1. Monitoring of products placed on the market To verify the products comply with applicable directives EC declaration of conformity and technical.

INTERFACES BETWEEN NATIONAL LEGISLATION AND DIRECTIVE 97/23/EC

mHealth subject to European regulation Dutch Stefan Visscher, PhD

National Legislation in the Pressure Sector and the PED

Presentation transcript:

Federal Agency for Medecines and Health Products Federal Agency for Medicines and Health Products (FAMHP) FAMHP/DLT/ Lambot Damien Materiovigilance Medical Device Vigilance

FAMHP/DLT Federal Agency for Medecines and Health Products 2 Medical Device Vigilance 1.Definitions and legal basis 1.1. Organigramme 1.2. Legal basis 1.3. Definitions Materiovigilance Medical Device Corrective Action Field Safety Corrective Action (FSCA) Field Safety Notice (FSN) 2. What shall be notify? 3. Who should be notify? 4. When must incidents be notified? 5. How should incidents be notified? 5.1. Users 5.2. Manufacturers, distributors, authorised representatives

FAMHP/DLT Federal Agency for Medecines and Health Products 3 1. Definitions and legal basis Medical Device Vigilance

FAMHP/DLT Federal Agency for Medecines and Health Products 4 1. Definitions and legal basis 1.1 Organigramme DG PRE authorisation DG POST authorisation DG INSPECTION R&D Division (human) Marketing Authorisation Division (human) Medicines for Veterinary use Division Assessors Division Marketing Authorisation Division Variations & Renewals Vigilance Division (pharmaco, materio, haemo, bio) Health Products Division Proper Use Division “Industry” Division “Dispensing” Division Control Policy Division SOE-USE Special Investigation Unitd’enquête

FAMHP/DLT Federal Agency for Medecines and Health Products 5 1. Definitions and legal basis 1.2 Legal basis Royal decrees: Royal decree 18/03/1999 (art. 11): Medical Device (MD) Royal decree 15/07/1997 (art. 12): Active Implantable Medical Device (AIMD) European Directives: Directive 93/42/EEC (MD) Directive 90/385/EEC (AIMD) Other: Guideline: MEDDEV rev 6: not legally binding

FAMHP/DLT Federal Agency for Medecines and Health Products 6 1. Definitions and legal basis 1.3 Definitions Materiovigilance The purpose of materiovigilance is to study and follow incidents that might result from using medical devices. It enables dangerous devices to be withdrawn from the market and to eliminate faults in medical devices with the intention of constantly improving the quality of devices and providing patients and users with increased safety. Materiovigilance only refers to medical devices whereas pharmacovigilance refers to medicines.

FAMHP/DLT Federal Agency for Medecines and Health Products 7 1. Definitions and legal basis Medical Device Medical device is defined as any instrument, equipment, material or other article used on its own or jointly, including software required for it to function correctly, which is intended by the manufacturer to be used on humans for the following purposes : for diagnostic, prevention, control, treating or diminishing an illness for diagnostic, control, treating, for diminishing or compensating an injury or handicap, for studying, replacing or modifying part of the anatomy or a physiological process for mastering conception and whose principal intended action in or on the human body is not obtained by pharmacological or immunological means or by metabolism but whose function can be assisted in such a way. More definition in the art. 1 of the law : accessory, active medical device, active implantable medical device, custom made device.

FAMHP/DLT Federal Agency for Medecines and Health Products 8 1. Definitions and legal basis 1.3.3: Corrective Action: Action to eliminate the cause of a potential non-conformity or other undesirable situation. NOTE1: There can be more than one cause for non- conformity. NOTE 2: Corrective action is taken to prevent recurrence whereas preventive action is taken to prevent occurrence.

FAMHP/DLT Federal Agency for Medecines and Health Products 9 1. Definitions and legal basis : Field Safety Corrective Action (FSCA): A FIELD SAFETY CORRECTIVE ACTION is an action taken by a MANUFACTURER to reduce a risk of death or serious deterioration in the state of health associated with the use of a MEDICAL DEVICE that is already placed on the market. Such actions should be notified via a FIELD SAFETY NOTICE. The FSCA may include - the return of a MEDICAL DEVICE to the supplier; - device modification; - device exchange; - device destruction; - retrofit by purchaser of MANUFACTURER's modification or design change; - advice given by MANUFACTURER regarding the use of the device (e.g. where the device is no longer on the market or has been withdrawn but could still possibly be in use) A device modification can include: - permanent or temporary changes to the labelling or instructions for use; - software upgrades including those carried out by remote access; - For implantable devices it is often clinically unjustifiable to explant the device. Corrective action taking the form of special patient follow-up, irrespective of whether any affected un-implanted devices remain available for return, constitutes FSCA.

FAMHP/DLT Federal Agency for Medecines and Health Products Definitions and legal basis Field Safety Notice (FSN) A communication to customers and/or USERs sent out by a MANUFACTURER or its representative in relation to a Field Safety Corrective Action.

FAMHP/DLT Federal Agency for Medecines and Health Products 11 Medical Device Vigilance 2. What shall be notify?

FAMHP/DLT Federal Agency for Medecines and Health Products 12 2.What shall be notify? - any dysfunction or any change of the characteristics and/or performance of a device, and any inadequacy in the labelling or instructions, which might lead to or have led to death or serious relapse in the state of health of a patient, a user or a third party. - any technical or medical reason related to the characteristics or performance of a device for reasons shown in the previous paragraph and having led to the systematic withdrawal from the market by a manufacturer of devices of the same type.

FAMHP/DLT Federal Agency for Medecines and Health Products 13 2.What shall be notify? Not only must one notify serious incidents which have actually taken place but also the cases where there was a risk of a serious incident but that incident was avoided thanks to the attention and action of the relevant people.

FAMHP/DLT Federal Agency for Medecines and Health Products 14 2.What shall be notify? Definition of an serious incident: An incident is considered serious if it has one of the following consequences or could have had such a consequence: - death, an illness or a handicap - a permanent lesion of a function or structure - the need for a medical or surgical operation - for a prolongation of a surgical operation - incorrect results of examinations leading to an incorrect diagnostic or treatment

FAMHP/DLT Federal Agency for Medecines and Health Products 15 2.What shall be notify? Examples: 1. An infusion pump stops, due to a malfunction, but gives an appropriate alarm (e.g. in compliance with relevant standards) and there was no injury to the patient.  do not need to be reported. 2. An infusion pump stops, due to a malfunction of the pump, but fails to give an appropriate alarm; there is no patient injury. This should be reported as in a different situation it could have caused a serious deterioration in state of health.

FAMHP/DLT Federal Agency for Medecines and Health Products 16 2.What shall be notify? 3. An aortic balloon catheter leaked because of inappropriate handling of the device in use, causing a situation which was potentially dangerous to the patient. It is believed that the inappropriate handling was due to inadequacies in the labelling. This incident should be reported. 4. A defect is discovered in one (hitherto unopened) sample of a batch (lot) of a contact lens disinfecting agent that could lead to incidence of microbial keratitis in some patients. The MANUFACTURER institutes a FSCA of this batch. The FSCA should be reported.

FAMHP/DLT Federal Agency for Medecines and Health Products 17 2.What shall be notify? 5. Loss of sensing after a pacemaker has reached end of life. Elective replacement indicator did not show up in due time, although it should have according to device specification. This INCIDENT should be reported. 6. The premature revision of an orthopedic implant is required due to loosening. Although no cause is yet determined, this INCIDENT should be reported.

FAMHP/DLT Federal Agency for Medecines and Health Products 18 Medical Device Vigilance 3. Who should be notify?

FAMHP/DLT Federal Agency for Medecines and Health Products Who should notify? Not only the manufacturers or their representatives but also persons distributing devices, notified bodies, practitioners and people responsible for receiving and/or delivering devices should all signal incidents to : Federal Agency for Medicines and Health Products – Vigilance Division. address :

FAMHP/DLT Federal Agency for Medecines and Health Products 20 Medical Device Vigilance 4. When must incidents be notified?

FAMHP/DLT Federal Agency for Medecines and Health Products When must incidents be notified? Incidents must be notified as quickly as possible using the quickest means possible. Incidents that have led to death or serious injury must be notified immediately.

FAMHP/DLT Federal Agency for Medecines and Health Products 22 Medical Device Vigilance 5. How should incidents be notified?

FAMHP/DLT Federal Agency for Medecines and Health Products How should incidents be notified? 5.1 User (pharmacist, doctors)   Human use  Medical devices and their accessories  How should incidents be notified

FAMHP/DLT Federal Agency for Medecines and Health Products How should incidents be notified?  devices/index_en.htm  Market surveillance and vigilance  Reference documents  Guidance  2.12 Market surveillance (Manufacturer Incident Report and Field safety Corrective Action) 5.2. Manufacturers, distributors, authorised representatives,…

FAMHP/DLT Federal Agency for Medecines and Health Products 25

FAMHP/DLT Federal Agency for Medecines and Health Products 26

FAMHP/DLT Federal Agency for Medecines and Health Products 27

FAMHP/DLT Federal Agency for Medecines and Health Products How should incidents be notified?

FAMHP/DLT Federal Agency for Medecines and Health Products How should incidents be notified? Documents to provide (FSCA): - The traceability data for Belgium (list of Belgian Customers, with quantities provided per lot number). - The model letter in our national languages (FSN) - Once available evidence that the users have received the letter and reconciliation data.

FAMHP/DLT Federal Agency for Medecines and Health Products 30 Links : Federal Agency for Medecines and Health Products : afmps.be/en/human_use/health_products/medical_devices_accessories/materiovigilance/index.jsp Belgian legislation: Market Surveillance and Vigilance on European Commission Web Site: Forms: -Distributor / Manufacturer /Authorized representative / …:  FSCA: devices/files/meddev/report_form_field_safety_corrective_action_en.dochttp://ec.europa.eu/enterprise/sectors/medical- devices/files/meddev/report_form_field_safety_corrective_action_en.doc  Incident: devices/files/meddev/report_form_manufacturers_incident_report_en.dochttp://ec.europa.eu/enterprise/sectors/medical- devices/files/meddev/report_form_manufacturers_incident_report_en.doc - User: afmps.be/fr/binaries/Copie%20de%20vigilance%20report%20%20FR%20vers _tcm _tcm xlshttp:// afmps.be/fr/binaries/Copie%20de%20vigilance%20report%20%20FR%20vers _tcm _tcm xls address of Health Product Division and Medical Device Vigilance Unit: